Effect of Agmatine on a mouse model of allergic airway inflammation: A comparative study.

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Mohammed K Еlmahdy, Rania R Abdelaziz, Hoda S Elmahdi, Ghada M Suddеk
{"title":"Effect of Agmatine on a mouse model of allergic airway inflammation: A comparative study.","authors":"Mohammed K Еlmahdy,&nbsp;Rania R Abdelaziz,&nbsp;Hoda S Elmahdi,&nbsp;Ghada M Suddеk","doi":"10.1080/08916934.2022.2093864","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Asthma is a chronic lung disease that injures and constricts the airways. This study evaluates the effects of agmatine on ovalbumin (OVA)-induced allergic inflammation of the airways.</p><p><strong>Methods: </strong>OVA sensitization by intraperitoneal injection was used to induce airway inflammation in mice on days 0 and 7; then the mice were challenged using beclomethasone (150 µg/kg, inhalation), a standard anti-asthmatic drug, from day 14 to day 16. Furthermore, agmatine (200 mg/kg) was intraperitoneally injected on day 0 and then daily for 16 days, followed by OVA challenge. The lung weight ratio, total and differential cell counts, TNF-α, interleukin-5 (IL-5) and IL-13 in bronchoalveolar lavage fluid (BALF), lung nitrite/nitrate (NO), and oxidative parameters were determined. Moreover, histopathological and immunohistochemical staining was employed.</p><p><strong>Results: </strong>Injection of agmatine (200 mg/kg) for 16 days significantly attenuated inflammation of the airways. The levels of BALF inflammatory cells, TNF-α, IL-5, IL-13, lung NO, and malondialdehyde (MDA), significantly decreased with concomitant elevation of superoxide dismutase (SOD) levels. Histological and immunohistochemical analyses of mast cells paralleled to biochemical improvements.</p><p><strong>Conclusion: </strong>Finally, this study illustrated that agmatine attenuates the allergic inflammation of airways caused by OVA by mitigating cytokines release, NO expression, and oxidative stress.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08916934.2022.2093864","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Asthma is a chronic lung disease that injures and constricts the airways. This study evaluates the effects of agmatine on ovalbumin (OVA)-induced allergic inflammation of the airways.

Methods: OVA sensitization by intraperitoneal injection was used to induce airway inflammation in mice on days 0 and 7; then the mice were challenged using beclomethasone (150 µg/kg, inhalation), a standard anti-asthmatic drug, from day 14 to day 16. Furthermore, agmatine (200 mg/kg) was intraperitoneally injected on day 0 and then daily for 16 days, followed by OVA challenge. The lung weight ratio, total and differential cell counts, TNF-α, interleukin-5 (IL-5) and IL-13 in bronchoalveolar lavage fluid (BALF), lung nitrite/nitrate (NO), and oxidative parameters were determined. Moreover, histopathological and immunohistochemical staining was employed.

Results: Injection of agmatine (200 mg/kg) for 16 days significantly attenuated inflammation of the airways. The levels of BALF inflammatory cells, TNF-α, IL-5, IL-13, lung NO, and malondialdehyde (MDA), significantly decreased with concomitant elevation of superoxide dismutase (SOD) levels. Histological and immunohistochemical analyses of mast cells paralleled to biochemical improvements.

Conclusion: Finally, this study illustrated that agmatine attenuates the allergic inflammation of airways caused by OVA by mitigating cytokines release, NO expression, and oxidative stress.

胍丁胺对小鼠变应性气道炎症模型影响的比较研究。
简介:哮喘是一种慢性肺部疾病,损害和收缩气道。本研究评估了胍丁氨酸对卵清蛋白(OVA)诱导的气道变应性炎症的影响。方法:采用腹腔注射OVA致敏法诱导小鼠气道炎症,时间分别为第0、7天;然后从第14天至第16天给小鼠注射标准抗哮喘药物倍氯米松(150µg/kg,吸入)。在第0天腹腔注射胍丁胺(200 mg/kg),然后每天注射,持续16天,然后进行卵细胞激发。测定肺重比、总细胞数和分化细胞数、支气管肺泡灌洗液(BALF)中TNF-α、白细胞介素-5 (IL-5)和IL-13、肺亚硝酸盐/硝酸盐(NO)及氧化参数。采用组织病理学和免疫组织化学染色。结果:胍丁胺(200mg /kg)连续注射16 d可明显减轻气道炎症反应。BALF炎症细胞、TNF-α、IL-5、IL-13、肺NO和丙二醛(MDA)水平随超氧化物歧化酶(SOD)水平升高而显著降低。肥大细胞的组织学和免疫组织化学分析与生化改善平行。结论:最后,本研究表明,agmatine通过减轻细胞因子释放、NO表达和氧化应激来减轻OVA引起的气道变应性炎症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信